Literature DB >> 30015796

Evaluation of Clinical Plus Imaging Features and Multidetector Computed Tomography Texture Analysis in Preoperative Risk Grade Prediction of Small Bowel Gastrointestinal Stromal Tumors.

Jiayi Yan, Xuesong Zhao, Shuai Han1, Ting Wang1, Fei Miao.   

Abstract

OBJECTIVE: This study aimed to evaluate the prediction roles of clinical plus imaging features and multidetector computed tomography (MDCT) texture analysis in preoperative risk grade classification of small bowel (SB) gastrointestinal stromal tumors (GISTs).
METHODS: This study included 213 SB GIST patients. Clinical features and MDCT imaging findings were reviewed. Tumor risk stratifications were determined according to modified National Institutes of Health criteria. Random forest models were performed to evaluate the correlation of risk stratification.
RESULTS: The model of clinical plus imaging findings showed an area under receiver operating characteristic curve (AUC) of 92.0%. The AUC of texture analysis based on MDCT portal phase was 93.3%, without statistical difference from that of clinical plus imaging model (P = 0.378). The AUC of the model combined clinical plus imaging features and MDCT texture analysis was 94.3%, which was significantly higher than the AUC of clinical imaging model (P = 0.042).
CONCLUSION: Texture analysis may become an important comprehensive tool for preoperative risk stratification of SB GISTs.

Entities:  

Mesh:

Year:  2018        PMID: 30015796     DOI: 10.1097/RCT.0000000000000756

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  9 in total

Review 1.  Standard Approach to Gastrointestinal Stromal Tumors - Differences between China and Europe.

Authors:  Lin Tu; Peter Hohenberger; Heike Allgayer; Hui Cao
Journal:  Visc Med       Date:  2018-10-19

Review 2.  Gastrointestinal stromal tumors: a comprehensive radiological review.

Authors:  Akitoshi Inoue; Shinichi Ota; Michio Yamasaki; Bolorkhand Batsaikhan; Akira Furukawa; Yoshiyuki Watanabe
Journal:  Jpn J Radiol       Date:  2022-07-09       Impact factor: 2.374

Review 3.  Current and Potential Applications of Artificial Intelligence in Gastrointestinal Stromal Tumor Imaging.

Authors:  Cai-Wei Yang; Xi-Jiao Liu; Si-Yun Liu; Shang Wan; Zheng Ye; Bin Song
Journal:  Contrast Media Mol Imaging       Date:  2020-11-26       Impact factor: 3.161

4.  CT Texture Analysis for Preoperative Identification of Lymphoma from Other Types of Primary Small Bowel Malignancies.

Authors:  Shunli Liu; Chuanyu Zhang; Ruiqing Liu; Shaoke Li; Fenglei Xu; Xuejun Liu; Zhiming Li; Yabin Hu; Yaqiong Ge; Jiao Chen; Zaixian Zhang
Journal:  Biomed Res Int       Date:  2021-04-02       Impact factor: 3.411

5.  Preoperative CT-Based Deep Learning Model for Predicting Risk Stratification in Patients With Gastrointestinal Stromal Tumors.

Authors:  Bing Kang; Xianshun Yuan; Hexiang Wang; Songnan Qin; Xuelin Song; Xinxin Yu; Shuai Zhang; Cong Sun; Qing Zhou; Ying Wei; Feng Shi; Shifeng Yang; Ximing Wang
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

6.  Malignancy risk of gastrointestinal stromal tumors evaluated with noninvasive radiomics: A multi-center study.

Authors:  Yun Wang; Yurui Wang; Jialiang Ren; Linyi Jia; Luyao Ma; Xiaoping Yin; Fei Yang; Bu-Lang Gao
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

Review 7.  Artificial intelligence in small intestinal diseases: Application and prospects.

Authors:  Yu Yang; Yu-Xuan Li; Ren-Qi Yao; Xiao-Hui Du; Chao Ren
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

Review 8.  Gastrointestinal Stromal Tumors of the Small Intestine: Progress in Diagnosis and Treatment Research.

Authors:  Fangxing Peng; Yao Liu
Journal:  Cancer Manag Res       Date:  2020-05-25       Impact factor: 3.989

Review 9.  New advances in radiomics of gastrointestinal stromal tumors.

Authors:  Roberto Cannella; Ludovico La Grutta; Massimo Midiri; Tommaso Vincenzo Bartolotta
Journal:  World J Gastroenterol       Date:  2020-08-28       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.